Real-World Outcomes With Inetetamab-Based Regimens for HER2-Positive Metastatic Breast Cancer: A Multicenter Retrospective Analysis in China.
Saved in:
| Title: | Real-World Outcomes With Inetetamab-Based Regimens for HER2-Positive Metastatic Breast Cancer: A Multicenter Retrospective Analysis in China. |
|---|---|
| Authors: | Zheng F; Department of Medical Oncology, Cancer Research Center, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China., Zhang J; Department of Medical Oncology, Cancer Research Center, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China., Zhou D; Department of Medical Oncology, Cancer Research Center, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China., Ren G; Department of Medical Oncology, Cancer Research Center, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China., Qiang L; Department of Medical Oncology, Cancer Research Center, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China., Wang T; Department of Medical Oncology, Cancer Research Center, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China., Pan F; Department of Medical Oncology, Cancer Research Center, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China., Shan C; Department of Oncology, Affiliated Hospital of Jining Medical College, Jining, China., Xia C; Department of Oncology, Affiliated Hospital of Jining Medical College, Jining, China., Yang F; Department of Oncology, Tengzhou Central People's Hospital, Tengzhou, China., Wang H; Department of Oncology, Tengzhou Central People's Hospital, Tengzhou, China., Liu G; Department II of Breast, Linyi Cancer Hospital, Linyi, China., Wang J; Department II of Breast, Linyi Cancer Hospital, Linyi, China., Hua R; Department of Medical Oncology, Cancer Research Center, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China., Du X; Department of Medical Oncology, Cancer Research Center, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China., Zhang B; Department of Medical Oncology, Cancer Research Center, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China., Li H; Department of Medical Oncology, Cancer Research Center, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China. |
| Source: | Cancer control : journal of the Moffitt Cancer Center [Cancer Control] 2026 Jan-Dec; Vol. 33, pp. 10732748261419187. Date of Electronic Publication: 2026 Jan 19. |
| Publication Type: | Journal Article; Multicenter Study |
| Journal Info: | Publisher: SAGE Publishing Country of Publication: United States NLM ID: 9438457 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1526-2359 (Electronic) Linking ISSN: 10732748 NLM ISO Abbreviation: Cancer Control Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1526-2359 |
|---|---|
| DOI: | 10.1177/10732748261419187 |
